Dawn Chen

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Dawn Chen worked as a Biochemistry Director at Arête Therapeutics, Inc. from 2006 to 2011.
Prior to that, she worked as a Principal at Vicuron Pharmaceuticals LLC and Affymax, Inc. Dr. Chen holds a graduate degree from the University of Alberta and a doctorate degree from Shanghai Jiao Tong University.

Precedenti posizioni note di Dawn Chen

Società	Posizione	Fine
Vicuron Pharmaceuticals LLC Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA.	Corporate Officer/Principal	-
AFFYMAX, INC.	Corporate Officer/Principal	-
Arête Therapeutics, Inc. Arête Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Arête Therapeutics, Inc. develops and commercializes molecule drugs to treat cardiovascular and inflammatory diseases. It focuses on developing AR9281, an orally-administered compound that inhibits s-EH (soluble epoxide hydrolase), an enzyme that plays a key role in the metabolism of arachidonic acid. It also focuses on testing various back-up candidates as additional first-in-class anti-hypertensive plus agents. The company was founded in 2003 and is headquartered in Hayward, CA.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Dawn Chen

Formazione di Dawn Chen

Shanghai Jiao Tong University	Doctorate Degree
University of Alberta	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private